A substantial number of cases of NSCLC and SCLC cases exhibit deletions or hypermethylation of the RASSF1A gene, ranging from 30% to 40% in NSCLC and as high as from 70% to 100% in SCLC. This evidence concerns the gene RASSF1 and non-small cell lung carcinoma.